Mahendra Gopaldas Shah's Insider Trades & SAST Disclosures
Mahendra Gopaldas Shah's most recent trade in Bolt Biotherapeutics Inc was a trade of 22,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 12, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mahendra Gopaldas Shah.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bolt Biotherapeutics Inc | Mahendra Gopaldas Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Impel Pharmaceuticals Inc | Mahendra Gopaldas Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 13,222 | 13,222 | - | - | Stock Option (right to buy) | |
| Impel Pharmaceuticals Inc | Mahendra Gopaldas Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 12,789 | 12,789 | - | - | Stock Option (right to buy) | |
| Bolt Biotherapeutics Inc | Mahendra Gopaldas Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Mahendra Gopaldas Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Impel Pharmaceuticals Inc | Mahendra Gopaldas Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2021 | 11,500 | 11,500 | - | - | Stock Option (right to buy) | |
| Bolt Biotherapeutics Inc | Mahendra Gopaldas Shah | Director | 09 Feb 2021 | 944,056 | 958,341 | - | - | Common Stock | ||
| Bolt Biotherapeutics Inc | Mahendra Gopaldas Shah | Director | 09 Feb 2021 | 944,056 | 0 | - | - | Series A- 1 Preferred Stock | ||
| Bolt Biotherapeutics Inc | Mahendra Gopaldas Shah | Director | 09 Feb 2021 | 472,296 | 1,430,637 | - | - | Common Stock | ||
| Bolt Biotherapeutics Inc | Mahendra Gopaldas Shah | Director | 09 Feb 2021 | 472,296 | 0 | - | - | Series B Preferred Stock | ||
| Bolt Biotherapeutics Inc | Mahendra Gopaldas Shah | Director | 09 Feb 2021 | 17,711 | 0 | - | - | Warrant (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Mahendra Gopaldas Shah | Director | 09 Feb 2021 | 17,711 | 1,448,348 | - | 0.1 | 1,240 | Common Stock | |
| Bolt Biotherapeutics Inc | Mahendra Gopaldas Shah | Director | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 09 Feb 2021 | 62 | 1,448,286 | - | 20 | 1,240 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges